REGULATION OF THE EXCRETORY FUNCTION OF THE KIDNEYS BY MEANS OF ADENOSINERGICAL AGENTS


Cite item

Full Text

Abstract

Aim - study of the effect of agonist and antagonists of adenosine receptors on the excretory function of the kidneys. Materials and methods. The experiments were carried out on white outbread rats. Experimental animals were injected subcutaneously with a pharmacological agent (natrii adenosinetriphosphate, natrii coffeinum-benzoate, euphyllinum, pentoxifylline), control - a similar volume of isotonic sodium chloride solution. All animals received an intra-gastric water load of 3% ofbody weight. The animals were placed in the exchange cells. The portions of urine (4 h and 24 h) were collected. In each sample, the volume, concentration of sodium, potassium and creatinine was determined. Results. A diuretical dose for pentoxifylline 0.7 mg/kg was established. The drug in this dose stimulated the excretory function of the kidneys by increasing the glomerular filtration and inhibiting tubular reabsorption. Consequently, pentoxifylline has a dual mechanism of diuretic action - tubular (similar to the action of furosemide at a threshold dose of 1 mg/kg) and an additional glomerular component. Conclusion. The search for diuretics among adenosine receptor blockers is promising, especially in the line of new selective adenosinergic drugs.

About the authors

EN N Zaitceva

Samara State Medical University

Email: 13zen31@mail.ru
hD, Associate Professor, head of the Department of Pharmacology of Samara State Medical University.

AV V Dubishchev

Samara State Medical University

Email: 13zen31@mail.ru
PhD, professor of the Department of Pharmacology of Samara State Medical University.

AA A Bazitova

Samara State Medical University

Email: a.bazitova@mail.ru
student of pediatric faculty of Samara State Medical University.

References

  1. Gessi S, Merighi S, Fazzi D et al. Adenosine receptor targeting in health end disease. Expert Opin. Investig. Drugs. 2011;20:1591 - 1609.
  2. Chen J, Eltzschig HK, Fredholm BB. Adenosine receptors as drug targets - what are the challenges. Nature Rev. Drug Discov. 2013;12: 265-286. 5
  3. Зайцева Е.Н., Дубищев А.В., Яковлев Д.С., Анисимова В.А. Нефропротекторные свойства соединения РУ-63 при экспериментальной острой почечной недостаточности в условиях гипергравитации. Экспериментальная и клиническая фармакология. 2016;79(3): 18-26.
  4. Яковлев Д.С., Колобродова Н.А., Спасов А.А., Анисимова В.А. Антиэметические свойства 5-НТ3-антагониста соединения РУ-1276. Экспериментальная и клиническая фармакология. 2015;78 (5):28-32.
  5. Зайцева Е.Н. Способ получения диуреза у лабораторных животных. Патент на изобретение RUS 2494703 06.02.2012. http://www1.fips.ru/fips_servl/fips_servlet
  6. Котельников Г.П., Шпигель А.С. Доказательная медицина. Научно-обоснованная медицинская практика. М.: «ГЭОТАР-Медиа», 2012.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2018 Zaitceva E.N., Dubishchev A.V., Bazitova A.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).